SHARE PURCHASE AGREEMENT

                            SHARE PURCHASE AGREEMENT

THIS  AGREEMENT  ("Agreement") is made and entered into effective this 27th  day
of  April,  2009,  by  and  between  and  among Pickford Minerals Inc., a Nevada
corporation,  ("Purchaser"), Novagen Solar (Canada) Ltd., a Canadian corporation
("Novagen"),  and  each of the undersigned shareholders of Novagen (collectively
referred  herein  as  "Shareholders").

                                    RECITALS

A.     Shareholders  are  the  legal  and  beneficial owners of 6,000,000 Common
shares without par value in the capital of Novagen, such shares being all of the
issued  and  outstanding  voting  shares  in  the  capital  of  the Company; and

B.     The  Shareholders  have agreed to sell to the Purchaser and the Purchaser
has agreed to purchase from the Shareholders all of the Shareholders' respective
legal  and  beneficial  interests in the shares in the capital of the Company on
the  terms  and  conditions  as  hereinafter  set  forth.

NOW  THEREFORE  in  consideration  of the premises and the mutual agreements and
covenants  herein  contained,  the  parties  hereto hereby covenant and agree as
follows:

ARTICLE  1  -  INTERPRETATION

1.1     DEFINED  TERMS.

In  this Agreement and in the schedules hereto, unless there is something in the
subject  matter  or  context  inconsistent  therewith,  the  following terms and
expressions  will  have  the  following  meanings:

"AFFILIATE"  of  any person means any corporation which, directly or indirectly,
is  controlled  by,  controls or is under direct or indirect common control with
such  person;

"ARM'S  LENGTH" will have the meaning ascribed to such term under the Income Tax
Act,  S.C.  1970-71-72,  c.  63  (Canada);

"FINANCIAL STATEMENTS" means the unaudited financial statements of Novagen as at
and  for  the  period  ended  March  31, 2009, consisting of a balance sheet, an
income statement, a statement of changes in financial position, and statement of
retained earnings and deficit, a copy of which is attached hereto as Schedule A,
all  prepared  in  accordance  with  generally  accepted  accounting principles,
consistently  applied;

"STATEMENTS  DATE"  means  the  date  of  the  Financial  Statements;

"BUSINESS" means the business carried on by Novagen which primarily involves the
sale  of  photovoltaic  products;

"BUSINESS DAY" means any day other than a day which is a Saturday, a Sunday or a
statutory  holiday  in  Toronto,  Ontario;

"CLOSING  DATE"  means  July 10, 2009, or such other date upon which the parties
may  agree;

"CLOSING  TIME" means 9:00 p.m. in Toronto, Ontario, on the Closing Date or such
other  time  on  the  Closing  Date  as  the  parties  hereto  may  agree  upon;

"CONDITION"  of  Novagen  means  the  condition  of  the  assets,  liabilities,
operations,  activities,  earnings,  prospects, affairs or financial position of
Novagen;

"CONTROL" means, with respect to any corporation, the ownership of more than 50%
of  the voting shares of that corporation, including any shares which are voting
only  upon  the  occurrence of a contingency where such contingency has occurred
and  is  continuing;

"ENCUMBRANCES"  means  mortgages,  charges,  pledges, security interests, liens,
encumbrances,  actions, claims, demands and equities of any nature whatsoever or
howsoever  arising  and  any rights or privileges capable of becoming any of the
foregoing;

"GENERALLY  ACCEPTED  ACCOUNTING  PRINCIPLES" means the accounting principles so
described  and  promulgated  by  the Canadian Institute of Chartered Accountants
which  are  applicable as at the date on which any calculation made hereunder is
to  be  effective  or  as  at  the  date of any financial statements referred to
herein,  as  the  case  may  be;

"INTERIM  PERIOD" means the period from and including the date of this Agreement
to  and  including  the  Closing  Date;

"LEASED  PREMISES"  means  all  premises  leased  by  Novagen  under the Leases;

"LICENCES"  means  all  of  the licences, registrations and qualifications to do
business  held  by  Novagen;

"PERSON"  means  and  includes  any  individual, corporation, partnership, firm,
joint venture, syndicate, association, trust, government, governmental agency or
board  or commission or authority, and any other form of entity or organization;

"PURCHASE  PRICE" means the aggregate consideration paid by the Purchaser to the
Shareholders  for  all  of  the  Purchased  Shares,  as  provided  herein;

"PURCHASED SHARES" means all the issued and outstanding shares in the capital of
Novagen being sold by the Shareholders and purchased by the Purchaser hereunder;

"WARRANTY  CLAIM" means a claim made by either the Purchaser or the Shareholders
based  on or with respect to the inaccuracy or non-performance or non-fulfilment
or breach of any representation or warranty made by the other party contained in
this  Agreement  or  contained  in any document or certificate given in order to
carry  out  the  transactions  contemplated  hereby.

1.2     BEST  OF  KNOWLEDGE.

Any  reference herein to "the best of the knowledge" of the Shareholders will be
deemed  to mean the actual knowledge of the Shareholders and the knowledge which
they  would  have had if they had conducted a diligent inquiry into the relevant
subject  matter.

1.3     SCHEDULES.

The  schedules  which  are attached to this Agreement are incorporated into this
Agreement  by  reference  and  are  deemed  to  be  part  hereof.

1.4     CURRENCY.

Unless otherwise indicated, all dollar amounts referred to in this Agreement are
in  lawful  money  of  the  United  States  of  America.

1.5     CHOICE  OF  LAW  AND  ATTORNMENT.

This Agreement shall be governed by and construed in accordance with the laws of
the  Province of Ontario and the laws of Canada applicable therein.  The parties
agree  that  the  courts  of  the  Province  of  Ontario  will  have  exclusive
jurisdiction  to  determine all disputes and claims arising between the parties.

1.6     INTERPRETATION  NOT  AFFECTED  BY  HEADINGS  OR  PARTY  DRAFTING.

The  division of this Agreement into articles, sections, paragraphs, subsections
and  clauses and the insertion of headings are for convenience of reference only
and  shall not affect the construction or interpretation of this Agreement.  The
terms  "this Agreement", "hereof", "herein", "hereunder" and similar expressions
refer  to  this  Agreement  and  the  schedules hereto and not to any particular
article,  section,  paragraph,  clause  or  other portion hereof and include any
agreement  or  instrument supplementary or ancillary hereto.  The parties hereto
acknowledge  that  their respective legal counsel have reviewed and participated
in  settling  the terms of this Agreement, and the parties hereby agree that any
rule  of construction to the effect that any ambiguity is to be resolved against
the  drafting  party  shall  not  be  applicable  in  the interpretation of this
Agreement.

1.7     NUMBER  AND  GENDER.

In  this  Agreement,  unless there is something in the subject matter or context
inconsistent  therewith:

(a)     words  in the singular number include the plural and such words shall be
construed  as  if  the  plural  had  been  used;

(b)     words  in  the  plural  include  the  singular  and  such words shall be
construed  as  if  the  singular  had  been  used,  and

(c)     words  importing  the  use of any gender shall include all genders where
the context or party referred to so requires, and the rest of the sentence shall
be construed as if the necessary grammatical and terminological changes had been
made.

1.8     TIME  OF  ESSENCE.

Time  shall  be  of  the  essence  hereof.

1.9     JOINT  AND  SEVERAL  OBLIGATIONS.

The  Shareholders'  obligations  hereunder  are  joint  and  several.

ARTICLE  2  -  PURCHASE  AND  SALE

2.1     PURCHASED  SHARES.

On the terms and subject to the fulfilment of the conditions hereof, the Vendors
will sell, assign and transfer to the Purchaser, and the Purchaser will purchase
and  accept  from  the  Shareholders,  the  Purchased  Shares.

2.2     PURCHASE  PRICE.

The  Purchase  Price  payable  by  the  Purchaser  to  the  Shareholders for the
Purchased  Shares  will  be  the  aggregate  of  6,000,000  fully  paid  and
non-assessable  voting  common  shares in the capital stock of the Purchaser, at
the  price  of  $0.01  per  share  (the  "Pickford  Shares").

2.3     PAYMENT  OF  PURCHASE  PRICE.

The  Purchase  Price  will  be  paid  as  follows:

(1)     At  the  Closing  Time,  Purchaser  shall  issue  one  fully  paid  and
non-assessable common share in the capital stock of the Purchaser to each of the
Shareholders  in  exchange  for  each  of  their  shares  of  Novagen.

(2)     Fahrinsland  Capital  LLC,  as  one  of the Shareholders, shall have the
right,  but not the obligation, to receive a convertible debenture issued by the
Purchaser  in  an  amount equal to the aggregate price of the Pickford Shares to
which  it  is  entitled  hereunder  (the  "Debenture").  The  Debenture  will be
non-interest  bearing,  convertible at the rate of $0.01 per share at the option
of  the  holder,  and  substantially  in  the form annexed hereto as Schedule H.

ARTICLE  3  -  REPRESENTATIONS  AND  WARRANTIES

3.1     REPRESENTATIONS  AND  WARRANTIES  BY  THE  SHAREHOLDERS.

The  Shareholders  hereby  jointly  and  severally  represent and warrant to the
Purchaser  as  follows,  and  confirm  that  the  Purchaser  is relying upon the
accuracy  of  each of such representations and warranties in connection with the
purchase  of  the  Purchased Shares and the completion of the other transactions
hereunder:

(1)     CORPORATE  AUTHORITY AND BINDING OBLIGATION.  The Shareholders have good
right,  full corporate power and absolute authority to enter into this Agreement
and  to  sell,  assign and transfer the Purchased Shares to the Purchaser in the
manner  contemplated  herein and to perform all of the Shareholders' obligations
under this Agreement.  Each of Novagen and the Shareholders and their respective
shareholders  and  boards  of  directors  have  taken all necessary or desirable
actions,  steps  and  corporate  and  other proceedings to approve or authorize,
validly  and  effectively,  the  entering  into, and the execution, delivery and
performance  of this Agreement and the sale and transfer of the Purchased Shares
by  the  Shareholders  to  the  Purchaser.  This Agreement is a legal, valid and
binding  obligation  of  the  Shareholders,  enforceable against each of them in
accordance  with  its  terms  subject  to:

(a)     bankruptcy,  insolvency,  moratorium,  reorganization  and  other  laws
relating  to  or  affecting  the enforcement of creditors' rights generally, and

(b)     the  fact  that  equitable  remedies, including the remedies of specific
performance  and  injunction,  may only be granted in the discretion of a court.

(2)     NO  OTHER  PURCHASE  AGREEMENTS.  No  person  has any agreement, option,
understanding  or  commitment,  or  any  right  or  privilege  (whether  by law,
pre-emptive  or  contractual)  capable  of  becoming  an  agreement,  option  or
commitment,  including  convertible  securities,  warrants  or  convertible
obligations  of  any  nature,  for:

(a)     the  purchase,  subscription,  allotment  or  issuance of, or conversion
into,  any of the unissued shares in the capital of Novagen or any securities of
Novagen;

(b)     the  purchase  from  the Shareholders of any of the Purchased Shares; or

(c)     the  purchase  or  other  acquisition  from  Novagen  of  any  of  its
undertaking,  property  or  assets,  other  than  in  the ordinary course of the
Business.

(3)     CONTRACTUAL  AND  REGULATORY  APPROVALS.  Neither  Novagen  nor  the
Shareholders  is  under  any obligation, contractual or otherwise, to request or
obtain  the  consent  of  any  person, and no permits, licenses, certifications,
authorizations  or  approvals  of, or notifications to, any federal, provincial,
municipal  or  local  government  or  governmental  agency, board, commission or
authority  are  required  to  be  obtained  by  Novagen  or  the  Shareholders:

(a)     in  connection  with  the  execution,  delivery  or  performance  by the
Shareholders  or  Novagen  of  this  Agreement  or  the completion of any of the
transactions  contemplated  herein;

(b)     to  avoid  the  loss  of  any  permit,  licence,  certification or other
authorization,  or

(c)     in  order  that the authority of Novagen to carry on the Business in the
ordinary  course  and  in the same manner as presently conducted remains in good
standing  and  in  full  force and effect as of and following the closing of the
transactions  contemplated  hereunder.

Complete  and  correct  copies  of  any  agreements  under  which Novagen or the
Shareholders  is  obligated  to  request  or  obtain  any such consent have been
provided  to  the  Purchaser.

(4)     STATUS,  CONSTATING  DOCUMENTS  AND  LICENCES.

(a)     Novagen is a corporation duly incorporated and validly subsisting in all
respects under the laws of Canada. Novagen is a "private company", as defined in
the  Securities  Act,  R.S.O.  1990,  c.S.5 (Ontario). Novagen has all necessary
corporate  power to own its properties and to carry on its business as it is now
being  conducted.

(b)     The  articles,  by-laws  and  other  constating documents of Novagen, as
amended  to  the  date  hereof,  are  listed  in Schedule B attached hereto, and
complete  and  correct  copies of each of those documents have been delivered to
the  Purchaser.

(c)     Novagen  is  duly licensed, registered and qualified as a corporation to
do  business,  is up-to-date in the filing of all required corporate returns and
other  notices and filings and is otherwise in good standing in all respects, in
each  jurisdiction  in  which:

(i)     it  owns  or  leases  property,  or

(ii)     the  nature  or  conduct  of  its  business or any part thereof, or the
nature  of the property of Novagen or any part thereof, makes such qualification
necessary  or desirable to enable the Business to be carried on as now conducted
or to enable the property and assets of Novagen to be owned, leased and operated
by  it.

All of Novagen's Licences are listed in Schedule C attached hereto and are valid
and subsisting.  Complete and correct copies of the Licences have been delivered
to the Purchaser.  Novagen is in compliance with all terms and conditions of the
Licences.  There  are no proceedings in progress, pending or, to the best of the
knowledge of the Shareholders, threatened, which could result in the revocation,
cancellation  or  suspension  of  any  of  the  Licences.

(5)     COMPLIANCE  WITH  CONSTATING  DOCUMENTS,  AGREEMENTS  AND  LAWS.  The
execution,  delivery  and  performance  of  this Agreement and each of the other
agreements  contemplated  or referred to herein by the Shareholders and Novagen,
and  the completion of the transactions contemplated hereby, will not constitute
or  result  in  a  violation  or  breach  of  or  default  under,  or  cause the
acceleration  of  any  obligations  of  Novagen  under:

(a)     any  term  or  provision  of  any  of  the  articles,  by-laws  or other
constating  documents  of  Novagen;

(b)     the  terms  of any agreement (written or oral), indenture, instrument or
understanding  or  other  obligation or restriction to which the  Novagen or the
Shareholders  is  a  party  or  by  which  either  of  them  is  bound;  or

(c)     any  term or provision of any of the Licences or any order of any court,
governmental  authority  or  regulatory  body  or  any  law or regulation of any
jurisdiction  in  which  the  Business  is  carried  on.

(6)     CORPORATE  RECORDS.  The  corporate records and minute books of Novagen,
all  of which have been provided to the Purchaser, contain complete and accurate
minutes  of all meetings of the directors and shareholders of Novagen held since
its  incorporation,  and  original  signed copies of all resolutions and by-laws
duly  passed or confirmed by the directors or shareholders of Novagen other than
at  a  meeting.  All  such  meetings  were  duly  called  and  held.  The  share
certificate  books,  register  of  security  holders,  register of transfers and
register  of directors and any similar corporate records of Novagen are complete
and  accurate.  All  exigible  security  transfer  tax or similar tax payable in
connection  with  the  transfer of any securities of Novagen has been duly paid.

(7)     AUTHORIZED  AND  ISSUED  CAPITAL.  The  authorized  capital  of  Novagen
consists  of an unlimited number of common shares and preferred shares, of which
6,000,000  common shares have been duly issued and are outstanding as fully paid
and  non-assessable  shares.  No shares or other securities of Novagen have been
issued in violation of any laws, the articles of incorporation, by-laws or other
constating  documents  of Novagen or the terms of any shareholders' agreement or
any  agreement  to  which  Novagen  is  a  party  or  by which it is bound.  The
Shareholders  own  all  of  the  issued and outstanding shares of Novagen as the
shareholder  of  record  and  as  the beneficial owner, with good and marketable
title  thereto,  free  and  clear  of  any  and  all  Encumbrances.

(8)     SHAREHOLDERS'  AGREEMENTS, ETC.   There are no shareholders' agreements,
pooling  agreements,  voting  trusts or other similar agreements with respect to
the  ownership  or  voting  of  any  of  the  shares  of  Novagen.

(9)     FINANCIAL  STATEMENTS.

(a)     The Financial Statements have been prepared in accordance with generally
accepted  accounting  principles, are true, correct and complete in all material
respects  and  present fairly the consolidated financial condition of Novagen as
of  March 31, 2009, including the consolidated assets and liabilities of Novagen
as of March 31, 2009, and the consolidated revenues, expenses and results of the
operations  of  Novagen  for  the  fiscal  year  ended  on  March  31,  2009.

(b)     The  financial  condition  of  Novagen  is  now  at least as good as the
financial  condition  reflected  in  the  Financial  Statements.

(10)     FINANCIAL RECORDS.  All material financial transactions of Novagen have
been  recorded  in the financial books and records of Novagen in accordance with
good  business  practice,  and  such  financial  books  and  records:

(a)     accurately  reflect in all material respects the basis for the financial
condition  and the revenues, expenses and results of operations of Novagen shown
in  the  Financial  Statements,  and

(b)     together with all disclosures made in this Agreement or in the Schedules
hereto,  present fairly in all material respects the financial condition and the
revenues,  expenses  and  results  of the operations of Novagen as of and to the
date  hereof.

No information, records or systems pertaining to the operation or administration
of  the  Business  are  in the possession of, recorded, stored, maintained by or
otherwise  dependent  upon  any  other  person.

(11)     LIABILITIES  OF  NOVAGEN.  Except as listed in Schedule D, there are no
liabilities  (contingent  or  otherwise)  of Novagen of any kind whatsoever, and
there  is no basis for assertion against Novagen of any liabilities of any kind,
other  than:

(a)     liabilities  disclosed  or reflected in or provided for in the Financial
Statements  or  the  Interim  Financial  Statements;

(b)     liabilities  incurred  since  the Statements Date which were incurred in
the  ordinary  course  of  the routine daily affairs of the Business and, in the
aggregate,  are  not  materially  adverse  to  the  Business,  and

(c)     other  liabilities  disclosed  in  this  Agreement  or  in the schedules
attached  hereto.

(12)     INDEBTEDNESS.  Except as disclosed in the Financial Statements, Novagen
has  no  bonds,  debentures,  mortgages,  promissory notes or other indebtedness
maturing  more  than  one  year  after  the  date  of their original creation or
issuance,  and  is  not  under  any  obligation  to  create  or issue any bonds,
debentures, mortgages, promissory notes or other indebtedness maturing more than
one  year  after  the  date  of  their  original  creation  or  issuance.

(13)     ABSENCE  OF  CERTAIN  CHANGES  OR  EVENTS.  Since  the Statements Date,
Novagen  has  not:

(a)     incurred  any  obligation  or  liability  (fixed  or contingent), except
normal  trade  or  business  obligations  incurred in the ordinary course of the
Business,  none  of  which  is  materially  adverse  to  Novagen;

(b)     paid  or  satisfied  any  obligation or liability (fixed or contingent),
except:

(i)     current  liabilities  included  in  the  Financial  Statements;

(ii)     current  liabilities incurred since the Statements Date in the ordinary
course  of  the  Business,  and

(iii)     scheduled  payments  pursuant  to obligations under loan agreements or
other  contracts  or commitments described in this Agreement or in the schedules
hereto.

(c)     created  any Encumbrance upon any of its properties or assets, except as
described  in  this  Agreement  or  in  the  schedules  hereto;

(d)     sold,  assigned, transferred, leased or otherwise disposed of any of its
properties  or  assets,  except  in  the  ordinary  course  of  the  Business;

(e)     purchased, leased or otherwise acquired any properties or assets, except
in  the  ordinary  course  of  the  Business;

(f)     waived, cancelled or written-off any rights, claims, accounts receivable
or  any  amounts  payable  to  Novagen,  except  in  the  ordinary course of the
Business;

(g)     entered  into any transaction, contract, agreement or commitment, except
in  the  ordinary  course  of  the  Business;

(h)     terminated,  discontinued,  closed or disposed of any plant, facility or
business  operation;

(i)     had  any  supplier terminate, or communicate to Novagen the intention or
threat  to  terminate  its  relationship  with  Novagen,  or  the  intention  to
substantially  reduce  the quantity of products or services it sells to Novagen,
except  in  the  case  of  suppliers  whose  sales  to  Novagen  are not, in the
aggregate,  material  to  the  Business  or  the  Condition  of  Novagen;

(j)     had  any  customer terminate, or communicate to Novagen the intention or
threat  to  terminate,  its  relationship  with  Novagen,  or  the  intention to
substantially  reduce  the  quantity  of  products or services it purchases from
Novagen,  or  its dissatisfaction with the products or services sold by Novagen,
except  in  the  case  of customers whose purchases from Novagen are not, in the
aggregate,  material  to  the  Business  or  the  Condition  of  Novagen;

(k)     made  any  material  change  in  the  method of billing customers or the
credit  terms  made  available  by  Novagen  to  its  customers;

(l)     made  any  material  change  with  respect  to any method of management,
operation  or  accounting  in  respect  of  the  Business;

(m)     suffered  any  damage,  destruction  or  loss (whether or not covered by
insurance) which has materially adversely affected or could materially adversely
affect  the  Business  or  the  Condition  of  Novagen;

(n)     increased  any  form  of  compensation  or  other benefits payable or to
become  payable to any of the employees of Novagen, except increases made in the
ordinary  course  of  the  Business  which  do  not exceed five per cent, in the
aggregate,  of the amount of the aggregate salary compensation payable to all of
Novagen's  employees  prior  to  such  increase;

(o)     suffered  any  extraordinary  loss  relating  to  the  Business;

(p)     made or incurred any material change in, or become aware of any event or
condition which is likely to result in a material change in, the Business or the
Condition  of  Novagen  or  its  relationships  with its customers, suppliers or
employees,  or

(q)     authorized,  agreed  or  otherwise  become  committed  to  do any of the
foregoing.

(14)     COMMITMENTS FOR CAPITAL EXPENDITURES.  Novagen is not committed to make
any  capital  expenditures, nor have any capital expenditures been authorized by
Novagen  at  any time since the Statements Date, except for capital expenditures
made  in the ordinary course of the routine daily affairs of the Business which,
in  the  aggregate,  do  not  exceed  $1,000.

(15)     DIVIDENDS  AND  DISTRIBUTIONS.  Since  the Statements Date, Novagen has
not  declared  or paid any dividend or made any other distribution on any of its
shares  of  any class, or redeemed or purchased or otherwise acquired any of its
shares  of  any  class,  or reduced its authorized capital or issued capital, or
agreed  to  any  of  the  foregoing.

(16)     TAX  MATTERS.

(a)     For  purposes  of  this Agreement, the term "Governmental Charges" means
and  includes  all  taxes,  customs  duties,  rates,  levies,  assessments,
reassessments and other charges, together with all penalties, interest and fines
with  respect  thereto,  payable to any federal, provincial, municipal, local or
other government or governmental agency, authority, board, bureau or commission,
domestic  or  foreign.

(b)     Novagen  has  duly  and  on  a  timely  basis prepared and filed all tax
returns  and  other  documents  required  to  be  filed  by it in respect of all
Governmental  Charges  and  such returns and documents are complete and correct.
Complete  and  correct  copies  of all such returns and other documents filed in
respect  of  the  three  fiscal years of Novagen ending prior to the date hereof
have  been  provided  to  the  Purchaser.

(c)     Novagen  has  paid all Governmental Charges which are due and payable by
it  on  or before the date hereof.  Adequate provision was made in the Financial
Statements for all Governmental Charges for the periods covered by the Financial
Statements,  respectively.  Novagen  has  no  liability for Governmental Charges
other  than  those provided for in the Financial Statements and those arising in
the  ordinary course of the operation of the Business since the Statements Date.

(d)     Canadian  federal and provincial income tax assessments have been issued
to  Novagen  covering all past periods up to and including the fiscal year ended
March  31,  2009.  There  are  no  actions,  suits, proceedings, investigations,
enquiries  or claims now pending or made or, to the best of the knowledge of the
Shareholders,  threatened  against  Novagen  in respect of Governmental Charges.

(e)     There are no agreements, waivers or other arrangements providing for any
extension of time with respect to the filing of any tax return or other document
or  the  payment  of  any  Governmental Charges by Novagen or the period for any
assessment  or  reassessment  of  Governmental Charges. Only the fiscal years of
Novagen subsequent to March 31, 2009 remain open for reassessment for additional
taxes.

(f)     Novagen has withheld from each amount paid or credited to any person the
amount  of  Governmental  Charges  required  to  be  withheld  therefrom and has
remitted  such  Governmental  Charges  to  the  proper  tax  or  other receiving
authorities  within  the  time  required  under  applicable  legislation.

(17)     LITIGATION.  There  are  no  actions, suits or proceedings, judicial or
administrative  (whether  or  not  purportedly  on  behalf  of  Novagen  or  the
Shareholders)  pending  or,  to  the  best of the knowledge of the Shareholders,
threatened,  by  or against or affecting Novagen, at law or in equity, or before
or  by  any  court  or  any federal, provincial, municipal or other governmental
department,  commission,  board,  bureau, agency or instrumentality, domestic or
foreign.   There  are  no  grounds  on which any such action, suit or proceeding
might  be  commenced  with  any  reasonable  likelihood  of  success.

(18)     TITLE  TO  ASSETS.  Novagen is the owner of and has good and marketable
title  to  all  of its properties and assets, including, without limitation, all
properties  and  assets reflected in the Financial Statements and all properties
and  assets acquired by Novagen after the Statements Date, free and clear of all
Encumbrances  whatsoever,  except  for:

(a)     the  properties  and assets disposed of, utilized or consumed by Novagen
since  the  Statements  Date  in  the  ordinary  course  of  the  Business;

(b)     the  Encumbrances  disclosed or reflected in the Financial Statements or
the  Interim  Financial  Statements;  and

(c)     liens  for  taxes  not  yet  due  and  payable.

No other person owns any assets which are being used in the Business, except for
the  Leased  Premises  and  personal  property  leased by Novagen.  There are no
agreements  or commitments to purchase property or assets by Novagen, other than
in  the  ordinary  course  of  the  Business.

(20)     DEPOSIT  ACCOUNTS  AND SAFE DEPOSIT BOXES OF NOVAGEN.  Novagen does not
have  any  deposit  accounts  or  safe  deposit  boxes.

(21)     SUBSIDIARIES AND OTHER INTERESTS.  Novagen has no subsidiaries and does
not  own  any  securities issued by, or any equity or ownership interest in, any
other person. Novagen is not subject to any obligation to make any investment in
or  to  provide  funds  by way of loan, capital contribution or otherwise to any
person.

(22)     PARTNERSHIPS  OR  JOINT  VENTURES.  Novagen  is  not  a  partner  or
participant  in  any  partnership,  joint venture, profit-sharing arrangement or
other  association  of  any  kind  and is not party to any agreement under which
Novagen  agrees  to  carry  on